Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Albumin Human

Research Leaders

6 sponsors active, led by Fresenius Medical Care North America

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 3 (1)

Trial Status

Completed2
Recruiting1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT06630923Phase 3Recruiting

PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PATIENTS

NCT04134377Not ApplicableCompleted

High-Protein Food Snack for Dialysis Patients

NCT04135872Completed

Hypoalbuminemia in Mild Acute Stroke and Cognitive Impariment Post-stroke

NCT03643523UnknownPrimary

Determination of Albumina as an Early Predictor of Postoperative Infections in Colorectal Surgery

Showing all 4 trials

Research Network

Common Treatments

  • Albumin Human1
  • Albumine Detection1
  • Protein Food Snack1
  • Strengthened Nuitritional Treatment1

Active Sponsors

  • Fresenius Medical Care North America1
  • University of Florida1
  • National Kidney Foundation, United States1
  • Corporacion Parc Tauli1
  • Democritus University of Thrace1

Top Investigators

Related Conditions

  • Diet Habit1
  • Heart Failure With Decompensation1
  • Diuretics Drug Reactions1
  • Cognitive Impairment1
  • Renal Failure1

Activity Timeline